Health-related quality of life for frail transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone: Subgroup analysis of MAIA Trial Meeting Abstract
| Authors: | Perrot, A.; Facon, T.; Plesner, T.; Usmani, S.; Kumar, S. K.; Bahlis, N. J.; Hulin, C.; Orlowski, R. Z.; Nahi, H.; Mollee, P.; Ramasamy, K.; Roussel, M.; Jaccard, A.; Delforge, M.; Karlin, L.; Arnulf, B.; Chari, A.; Pei, H.; Gupta, N.; Kaila, S.; Matt, K.; Gries, K. S.; Carson, R.; Borgsten, F.; Weisel, K. |
| Abstract Title: | Health-related quality of life for frail transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone: Subgroup analysis of MAIA Trial |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 1142 |
| End Page: | 1145 |
| Language: | English |
| ACCESSION: | WOS:000893223201058 |
| DOI: | 10.1182/blood-2022-165524 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
